Pharma Consolidation Ahead In Indonesia

Because of intense competitive pressure, two Indonesian pharmaceutical companies have agreed to merge. Following the completion of feasibility studies and legal processes, the integration of PT Kimia Farma and PT Indofarma is expected by Q409. BMI notes that the deal once again underlines our core view that M&A activity will increase due to the efficiencies realised from

To read the full article, please choose one of the following options: